|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023821,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0220901,
umls-concept:C0360714,
umls-concept:C0543421,
umls-concept:C0700164,
umls-concept:C0729627,
umls-concept:C0948089,
umls-concept:C1274040,
umls-concept:C2698872
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-2-20
|
|
pubmed:abstractText |
The purpose of this study was to compare the prognostic utility of apoB/AI, total cholesterol/HDL (TC/HDL) ratio, non-HDL cholesterol (non-HDL-C), or hs-CRP as predictors of clinical risk among patients receiving statin therapy after acute coronary syndromes (ACS).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/APOA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins B,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
424-30
|
|
pubmed:meshHeading |
pubmed-meshheading:19122170-Acute Coronary Syndrome,
pubmed-meshheading:19122170-Apolipoprotein A-I,
pubmed-meshheading:19122170-Apolipoproteins B,
pubmed-meshheading:19122170-Biological Markers,
pubmed-meshheading:19122170-C-Reactive Protein,
pubmed-meshheading:19122170-Cholesterol,
pubmed-meshheading:19122170-Cholesterol, HDL,
pubmed-meshheading:19122170-Coronary Disease,
pubmed-meshheading:19122170-Female,
pubmed-meshheading:19122170-Heptanoic Acids,
pubmed-meshheading:19122170-Humans,
pubmed-meshheading:19122170-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:19122170-Male,
pubmed-meshheading:19122170-Middle Aged,
pubmed-meshheading:19122170-Pravastatin,
pubmed-meshheading:19122170-Predictive Value of Tests,
pubmed-meshheading:19122170-Proportional Hazards Models,
pubmed-meshheading:19122170-Pyrroles,
pubmed-meshheading:19122170-Recurrence,
pubmed-meshheading:19122170-Risk Assessment,
pubmed-meshheading:19122170-Time Factors,
pubmed-meshheading:19122170-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
|
|
pubmed:affiliation |
TIMI Study Group, Cardiovascular Division and the Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, MA 02115, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
